CRMZ News Alert Creditriskmonitor.Com Inc (CRMZ) 2.9800 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Creditriskmonitor.Com Inc (CRMZ) 2.9800 $CRMZ

CreditRiskMonitor Hires Information Industry Veteran to Head Marketing
ACCESSWIRE - Wed Nov 19, 2:15PM CST
VALLEY COTTAGE, NY / ACCESSWIRE / November 19, 2014 / CreditRiskMonitor (OTCQX: CRMZ), announced today the appointment of Patricia A. McParland as Senior Vice President of Marketing. She will report to William Danner, President.

CreditRiskMonitor Declares Special Dividend and Announces Stock Repurchase Plan
ACCESSWIRE - Tue Oct 28, 1:16PM CDT
VALLEY COTTAGE, NY / ACCESSWIRE / October 28, 2014 / CreditRiskMonitor (OTCQX: CRMZ), announced that its Board of Directors has declared a special dividend of $0.05 per outstanding share of its common stock. The dividend will be payable on November 28, 2014 to shareholders of record of the Company at the close of business on November 12, 2014. The Board also authorized the Company to repurchase up to $1 million of its common stock through the end of fiscal 2015.

CreditRiskMonitor Announces 2Q Results
ACCESSWIRE - Fri Aug 08, 6:49AM CDT
VALLEY COTTAGE, NY / ACCESSWIRE / August 8, 2014 / CreditRiskMonitor (OTCQX: CRMZ) reported that revenues increased 2% and 3% to $3.00 million and $5.97 million for the 3 and 6 months ended June 30, 2014, respectively, compared to prior year periods. For the same periods, income from operations was $262,100 and $127,000, respectively, compared to $109,700 and $168,300 for the comparable 2013 periods. Cash, cash equivalents and marketable securities at the end of the six-month period increased $737,000 to $8.78 million versus the 2013 year-end balance of $8.05 million.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading